NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) Status COMPLETED Phase PHASE2
NCT04351191 PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds Status TERMINATED Phase PHASE4
NCT04350723 Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE) Status COMPLETED Phase NA
NCT04350593 Dapagliflozin in Respiratory Failure in Patients With COVID-19 Status COMPLETED Phase PHASE3
NCT04350450 Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore Status WITHDRAWN Phase PHASE2
NCT04350073 Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) Status COMPLETED Phase N/A
NCT04349631 A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19 Status COMPLETED Phase PHASE2
NCT04349202 Beaumont Health Large-scale Automated Serologic Testing for COVID-19 Status COMPLETED Phase N/A
NCT04348656 CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) Status TERMINATED Phase PHASE3
NCT04348513 Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection Status TERMINATED Phase PHASE2
NCT04348500 Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19) Status COMPLETED Phase PHASE2
NCT04348474 Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19 Status SUSPENDED Phase EARLY_PHASE1